A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.
Eligibility criteria
Qualifiers
≥18 years old; AND
Scheduled for valve procedures
Disqualifiers
Congenital heart disease (except for bicuspid aortic valve), OR
Carcinoid heart disease, OR
Valvular mass, OR
Endocarditis, OR
Trial design
Treatments tested in this trial
- Echocardiogram
Treatment groups
600 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov